Enacted January 10, 1994
Recently revised October 13, 2022
Journal of Rheumatic Diseases (JRD) aims to liberate patients with rheumatic diseases from the pain and disabilities that originated from the diseases by providing essential medical knowledge and safe practices. Its scope is all aspects of rheumatic diseases, including clinical investigations and basic research. Both human and experimental animal studies are welcome. New findings on the epidemiology, pathogenesis, diagnosis and treatment of rheumatic diseases are core targets of the journal. Its regional focus is mainly Korea, but it also welcomes submissions from researchers and physicians all over the world. Its publication type includes original articles, reviews, case reports, clinical images, recommendations and guidelines and editorials but does not exclude other types.
Journal of Rheumatic Diseases (JRD) is the official journal of the Korean College (KCR) of Rheumatology and the Korean College of Pediatric Clinical Immunology. Anyone who would like to submit a manuscript is advised to carefully read the aims and scope section of this journal. Manuscripts should be prepared for submission to JRD according to the "Information to Author". For issues not addressed in these instructions, the author is referred to the International Committee of Medical Journal Editors (ICMJE) "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" (http://www.icmje.org).
Compliance with ICMJE Recommendations: The journal adheres completely to the ethical guidelines for research and publication described in Guidelines on Good Publication (http://publicationethics.org/resources/guidelines), the ICMJE Guidelines (http://www.icmje.org), and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice).
It is not allowed for another journal to publish a manuscript that is the same as or similar to that submitted to the JRD. In addition, the KCR possesses the copyright of a manuscript whose publishing has been decided and is authorized to publish, distribute or print the manuscript in the JRD or other media.
We accept submissions only through our online manuscript submission system (https://www.editorialmanager.com/jrds/). Please do not submit manuscripts as electronic mail attachments or by regular mail.
Every manuscript submitted should be double-blind peer-reviewed by two or more relevant experts (3 most relevant investigators available for review of the original article and case report), as regards the appropriateness of publishing. Its publishing should be decided on the basis of the deliberation and its author may be advised to revise or complement its content. Advised to revise its content, the author should revise the manuscript and submit the revised manuscript along with his/her answer on the processing of the items pointed out by judges in a file form.
All manuscripts from editors, employees, or members of the editorial board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts even if they are commissioned ones.
The revised manuscript should be resubmitted via the web system. Failure to resubmit the revised manuscript within 2 months without any notice from the corresponding author is regarded as a withdrawal.
1. Reporting guidelines for specific study design
Research reports frequently omit important information. As such, reporting guidelines have been developed for a number of study designs that some journals may ask authors to follow. Authors are encouraged to also consult the reporting guidelines relevant to their specific research design. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/ National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html).
2. Organization of manuscripts
The original article should contain, in the following order: title page, abstract, keywords, running title, main text (introduction, materials and methods, results, discussion, conclusion), supplementary data, funding, acknowledgments, conflict of interest, author contributions, ORCID, references, tables and figures.
A preprint can be defined as a version of a scholarly paper that precedes formal peer review and publication in a peer-reviewed scholarly journal. Journal of Rheumatic Diseases (JRD) allows authors to submit the preprint to the journal. It is not treated as duplicate submission or duplicate publication. JRD recommend authors to disclose it with DOI in the letter to the editor during the submission process. Otherwise, it may be screened from the plagiarism check program — Similarity Check (Crosscheck).
Preprint submission will be processed through the same peer-review process with a usual submission. If the preprint is accepted for publication, authors are recommended to update the info at the preprint with a link to the published article in JRD, including DOI at JRD. It is strongly recommended that authors cite the article in JRD instead of the preprint.
For general matters and cautions, other manuscripts should follow an original article.
Ji-Hyoun Kang, M.D., Ph.D., Sung-Eun Choi, M.D., Dong-Jin Park, M.D., Ph.D., Shin-Seok Lee, M.D., Ph.D.J Rheum Dis 2022;29: 4-13
Chong Hyuk Chung, M.D.*, Gyuho Jang, M.D.*, Chang-Hoon Lee, M.D., Ph.D.J Rheum Dis 2021;28: 31-37
Hyoungyoung Kim, M.D., M.S., Yoon-Kyoung Sung, M.D., Ph.D., MPHJ Rheum Dis 2021;28: 60-67
Robert D Inman, M.D., FRCPC, FACP, FRCP EdinJ Rheum Dis 2021;28: 55-59